Stock screenerAll disclosures →
EDGAR →
IRD
Conviction 76HealthcareScan · Thu, Sep 24, 2026Opus Genetics, Inc. (IRD) closed at $4.88 (+0.93%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 52, RS Rating 98, -19.7% from its 52-week high, +130.0% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.
IRD$4.88+0.93%
ResistanceSupportVol 14Insider sell4
Vol MA14 6.67M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price4.88
Change+0.93%
Gap-1.55%
Rel volume0.63×
Avg volume5.28M
Avg $ vol28.79M
SMA 204.93
SMA 504.14
SMA 2003.91
Price vs 50+17.88%
Price vs 200+24.56%
MA stackbullish
50/200 cross—
Supertrendup · 4.45
RSI (14)52
MACD hist-0.09
MACD crossbear · 2d
Stoch %K / %D21 / 27
ADX (14)38
+DI / −DI32 / 20
RSI divergence—
MACD divergence—
ATR %9.37%
ADR %9.25%
52w high6.07
52w low1.64
From 52w high-19.69%
Above 52w low+197.26%
New 52w highNo
SqueezeOff
Bollinger width62.81%
%B0.48
Donchian pos38.33%
Donchian high7.07
Donchian low3.51
AVWAP (52w high)5.84
vs AVWAP high-16.48%
AVWAP (52w low)4.37
vs AVWAP low+11.65%
OBV trendUp
Chaikin MF (20)-0.26
Today vs 20d0.63×
Avg vol (14d)6.67M
Avg vol (20d)5.28M
Avg $ vol (20d)28.79M
Market cap405.58M
RS Rating98 / 99
RS 3m (vs SPY)+26.56%
RS 6m (vs SPY)-14.19%
RS line new highNo
Trend template7/8
Technical rank78.8
1 week-7.67%
1 month+18.61%
3 months+31.05%
6 months+2.63%
1 year+193.67%
YTD+129.95%
P/E-8.18
P/B-31.23
P/S28.57
P/FCF-11.50
EPS-0.8000
Div yield—
ROE381.88%
ROA-53.34%
Debt/Eq-0.09
Current12.19
EV/EBITDA-8.25
Gross margin—
Net margin-349.33%
Rev growth29.15%
EPS growth13.80%
Price target13.08
Target upside168.31%
Analyst ratingBuy
Institutional71.75%
Ent. value317.97M
Revenue755K
Net income-8.1M
Gross profit—
Free cash flow-35.25M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out82.57M
Employees28
ListedFri, Nov 6, 2020
Free float56.1M
Float %78.9%
Short interest10.91M
Days to cover12.4d
Short volume46.4%
Squeeze score68 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.14 vs −$0.15
Last surprise+6.7% beat
Setup gradeA
Conviction76 / 100
Pattern quality—
Tech rank78.8 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance5.95
Support3.53
Days since event—
Candle confirm—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in IRD
No recent disclosed trades by Congress in IRD. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in IRD · open-market 7 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Magrath George Chief Executive Officer · Common Stock · 2026-09-09 | Exercise | 392.16K | $451K | 2026-09-09 | 2026-09-11 |
Magrath George Chief Executive Officer · Common Stock · 2026-09-09 | Tax | 75.54K | $451K | 2026-09-09 | 2026-09-11 |
Magrath George Chief Executive Officer · Warrant (right to buy) · 2026-09-09 | Exercise | 392.16K | — | 2026-09-09 | 2026-09-11 |
Gagnon Robert E. Chief Financial Officer · Common Stock · 2026-07-23 | Sell | 7.78K | $23K | 2026-07-23 | 2026-07-27 |
Magrath George Chief Executive Officer · Common Stock · 2026-07-23 | Sell | 9.47K | $28K | 2026-07-23 | 2026-07-27 |
SCHACHLE JOSEPH K Chief Operating Officer · Common Stock · 2026-07-23 | Sell | 4.64K | $14K | 2026-07-23 | 2026-07-27 |
YERXA BENJAMIN R President · Common Stock · 2026-07-23 | Sell | 7.43K | $22K | 2026-07-23 | 2026-07-27 |
Foundation Fighting Blindness Retinal Degeneration Fund Director · Common Stock · 2026-05-18 | Sell | 1.7M | $7.4M | 2026-05-18 | 2026-05-20 |
Foundation Fighting Blindness, Inc. Director · Common Stock · 2026-05-18 | Sell | 1.7M | $7.4M | 2026-05-18 | 2026-05-20 |
SCHACHLE JOSEPH K Chief Operating Officer · Common Stock · 2026-04-23 | Sell | 4.7K | $25K | 2026-04-23 | 2026-04-27 |
SEC filings
EDGAR filings in IRD · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.